Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) FCF Margin (2020 - 2025)

Historic FCF Margin for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to 4.67%.

  • LifeStance Health's FCF Margin fell 9800.0% to 4.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.73%, marking a year-over-year increase of 58200.0%. This contributed to the annual value of 6.85% for FY2024, which is 122900.0% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's FCF Margin is 4.67%, which was down 9800.0% from 16.4% recorded in Q2 2025.
  • LifeStance Health's 5-year FCF Margin high stood at 17.21% for Q4 2024, and its period low was 13.37% during Q3 2023.
  • Over the past 5 years, LifeStance Health's median FCF Margin value was 3.08% (recorded in 2025), while the average stood at 0.19%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -112900bps in 2022, then skyrocketed by 190200bps in 2024.
  • Over the past 5 years, LifeStance Health's FCF Margin (Quarter) stood at 4.23% in 2021, then soared by 363bps to 11.13% in 2022, then crashed by -83bps to 1.92% in 2023, then surged by 797bps to 17.21% in 2024, then plummeted by -73bps to 4.67% in 2025.
  • Its FCF Margin was 4.67% in Q3 2025, compared to 16.4% in Q2 2025 and 3.08% in Q1 2025.